SR-48692, A NONPEPTIDE NEUROTENSIN RECEPTOR ANTAGONIST, BLOCKS THE CARDIOVASCULAR EFFECTS ELICITED BY NEUROTENSIN IN GUINEA-PIGS

被引:11
|
作者
NISATO, D [1 ]
GUIRAUDOU, P [1 ]
BARTHELEMY, G [1 ]
GULLY, D [1 ]
LEFUR, G [1 ]
机构
[1] SANOFI RECH,F-31036 TOULOUSE,FRANCE
关键词
D O I
10.1016/0024-3205(94)00411-0
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In guinea pigs anaesthetized with sodium pentobarbital, SR 48692, a non peptide neurotensin receptor antagonist blunted the blood pressure increase induced by exogenous neurotensin in a dose dependent manner. Furthermore, in isolated spontaneously beating guinea pig atria, both the tachycardia and inotropic responses induced by neurotensin were potently antagonized. SR 48692 did not show any intrinsic effect in vivo or in vitro.
引用
收藏
页码:PL95 / PL100
页数:6
相关论文
共 50 条
  • [21] THE NONPEPTIDE NEUROTENSIN RECEPTOR ANTAGONIST SR48692 IS NOT A POTENT ANTAGONIST OF NEUROTENSIN(8-13) RESPONSES OF RAT SUBSTANTIA-NIGRA NEURONS IN-VITRO
    PINNOCK, RD
    WOODRUFF, GN
    NEUROSCIENCE LETTERS, 1994, 172 (1-2) : 175 - 178
  • [22] The neurotensin receptor antagonist SR 48692, decreases extracellular striatal GABA in rats
    Chapman, MA
    See, RE
    BRAIN RESEARCH, 1996, 729 (01) : 124 - 126
  • [23] HEMODYNAMIC AND ABDOMINAL MOTOR REFLEXES ELICITED BY NEUROTENSIN IN ANESTHETIZED GUINEA-PIGS
    RIOUX, F
    LEMIEUX, M
    BRITISH JOURNAL OF PHARMACOLOGY, 1992, 106 (01) : 187 - 195
  • [24] The identification of nonpeptide neurotensin receptor partial agonists from the potent antagonist SR48692 using a calcium mobilization assay
    Thomas, James B.
    Navarro, Hernan
    Warner, Keith R.
    Gilmour, Brian
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (05) : 1438 - 1441
  • [25] PARTICIPATION OF CAPSAICIN-SENSITIVE NEURONS IN THE CARDIOVASCULAR EFFECTS OF NEUROTENSIN IN GUINEA-PIGS
    BACHELARD, H
    STPIERRE, S
    RIOUX, F
    PEPTIDES, 1987, 8 (06) : 1079 - 1087
  • [26] THE CARDIOVASCULAR-RESPONSE TO EPICARDIAL APPLICATION OF NEUROTENSIN IN GUINEA-PIGS
    RIOUX, F
    BACHELARD, H
    BARABE, J
    STPIERRE, S
    PEPTIDES, 1986, 7 (06) : 1087 - 1094
  • [27] SR 48692, a specific neurotensin receptor antagonist, has no effect on oesophageal motility in humans
    Zerbib, F
    Piche, T
    Charles, F
    Galmiche, JP
    Des Varannes, SB
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (08) : 931 - 939
  • [28] Dose-dependent pain-facilitatory and -inhibitory actions of neurotensin are revealed by SR 48692, a nonpeptide neurotensin antagonist: Influence on the antinociceptive effect of morphine
    Smith, DJ
    Hawranko, AA
    Monroe, PJ
    Gully, D
    Urban, MO
    Craig, CR
    Smith, JP
    Smith, DL
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 282 (02): : 899 - 908
  • [29] SR142948A is a potent antagonist of the cardiovascular effects of neurotensin
    Schaeffer, P
    Laplace, MC
    Bernat, A
    Prabonnaud, V
    Gully, D
    Lespy, L
    Herbert, JM
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 (04) : 545 - 550
  • [30] Neurotensin receptor antagonist, SR48692, sensitizes prostate cancer cells to radiation in vitro and in vivo
    Casarez, Eli V.
    DaSilva, John O.
    Valerie, Nicholas C. K.
    Anaganti, Suresh
    Dunlap-Brown, Marya E.
    Amorino, George P.
    Larner, James M.
    Parsons, Sarah J.
    Dziegielewski, Jaroslaw
    CANCER RESEARCH, 2011, 71